HealthJun 05, 2026

Imunon raises $10.0M (Jun 2026)

$10.0M
10 Million Dollars
Generated social card
Imunon social card
Headline

Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial - HarianBasis.co

About

Imunon is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is currently conducting a trial for ovarian cancer, which is a significant area of need in oncology. This funding will support their efforts to advance their clinical programs.

Article summary

Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial  HarianBasis.co

Investors
Related rounds
Jul 13, 2026Corner Health$32.5MSeed and Series AUnited States
Jul 11, 2026TJM Labs$100.0MSeries BUnited States
Jul 11, 2026Cent$5.0M——
Jul 10, 2026Upside$20.0MSeries AUnited States